Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tetsuya Hosaka

Showing results (31-40 of 318) with videos related to

Pageof 32
Sort By:
Journal of Gastroenterology|May 29, 2007
Factors associated with the virological response of lamivudine-resistant hepatitis B virus during combination therapy with adefovir dipivoxil plus lamivudineTetsuya Hosaka, Fumitaka Suzuki, Yoshiyuki Suzuki, et al.
Journal of Gastroenterology and Hepatology|December 22, 2004
Significance of hepatitis B virus DNA clearance and early prediction of hepatocellular carcinogenesis in patients with cirrhosis undergoing interferon therapy: long-term follow up of a pilot studyKenji Ikeda, Masahiro Kobayashi, Satoshi Saitoh, et al.
Journal of Gastroenterology|April 8, 2004
High-dose interferon alpha-2b induction therapy in combination with ribavirin for Japanese patients infected with hepatitis C virus genotype 1b with a high baseline viral loadAkihito Tsubota, Yasuji Arase, Fumitaka Suzuki, et al.
Journal of Medical Virology|October 15, 2013
Correlation between hepatitis B virus surface antigen level and alpha-fetoprotein in patients free of hepatocellular carcinoma or severe hepatitisNorio Akuta, Fumitaka Suzuki, Mariko Kobayashi, et al.
Journal of Medical Virology|November 16, 2004
Early viral kinetics and treatment outcome in combination of high-dose interferon induction vs. pegylated interferon plus ribavirin for naive patients infected with hepatitis C virus of genotype 1b and high viral loadAkihito Tsubota, Yasuji Arase, Takashi Someya, et al.
Journal of Gastroenterology|April 8, 2004
Successful control of ruptured hepatocellular carcinoma with radiofrequency ablationMasahiro Kobayashi, Kenji Ikeda, Tetsuya Hosaka, et al.
Intervirology|November 27, 2004
Benefit of lamivudine therapy and factors associated with clinical outcome in spontaneous severe acute exacerbation of chronic hepatitis B virus infectionAkihito Tsubota, Yasuji Arase, Yoshiyuki Suzuki, et al.
Intervirology|August 24, 2006
Long-term follow-up of HBeAg-positive young adult Japanese patients treated with corticosteroid withdrawal therapy for chronic hepatitis BHitomi Sezaki, Fumitaka Suzuki, Tetsuya Hosaka, et al.
Oncology|December 6, 2003
Recurrence rate and prognosis of patients with hepatocellular carcinoma that developed after elimination of hepatitis C virus RNA by interferon therapy. A closed cohort study including matched control patientsKenji Ikeda, Masahiro Kobayashi, Satoshi Saitoh, et al.
Intervirology|March 24, 2005
Hepatitis B virus-related hepatocellular carcinogenesis and its preventionKenji Ikeda, Yasuji Arase, Masahiro Kobayashi, et al.
Pageof 32

Showing results (31-40 of 318) with videos related to

Sort By:
Pageof 32
Journal of Gastroenterology|May 29, 2007
Factors associated with the virological response of lamivudine-resistant hepatitis B virus during combination therapy with adefovir dipivoxil plus lamivudineTetsuya Hosaka, Fumitaka Suzuki, Yoshiyuki Suzuki, et al.
Journal of Gastroenterology and Hepatology|December 22, 2004
Significance of hepatitis B virus DNA clearance and early prediction of hepatocellular carcinogenesis in patients with cirrhosis undergoing interferon therapy: long-term follow up of a pilot studyKenji Ikeda, Masahiro Kobayashi, Satoshi Saitoh, et al.
Journal of Gastroenterology|April 8, 2004
High-dose interferon alpha-2b induction therapy in combination with ribavirin for Japanese patients infected with hepatitis C virus genotype 1b with a high baseline viral loadAkihito Tsubota, Yasuji Arase, Fumitaka Suzuki, et al.
Journal of Medical Virology|October 15, 2013
Correlation between hepatitis B virus surface antigen level and alpha-fetoprotein in patients free of hepatocellular carcinoma or severe hepatitisNorio Akuta, Fumitaka Suzuki, Mariko Kobayashi, et al.
Journal of Medical Virology|November 16, 2004
Early viral kinetics and treatment outcome in combination of high-dose interferon induction vs. pegylated interferon plus ribavirin for naive patients infected with hepatitis C virus of genotype 1b and high viral loadAkihito Tsubota, Yasuji Arase, Takashi Someya, et al.
Journal of Gastroenterology|April 8, 2004
Successful control of ruptured hepatocellular carcinoma with radiofrequency ablationMasahiro Kobayashi, Kenji Ikeda, Tetsuya Hosaka, et al.
Intervirology|November 27, 2004
Benefit of lamivudine therapy and factors associated with clinical outcome in spontaneous severe acute exacerbation of chronic hepatitis B virus infectionAkihito Tsubota, Yasuji Arase, Yoshiyuki Suzuki, et al.
Intervirology|August 24, 2006
Long-term follow-up of HBeAg-positive young adult Japanese patients treated with corticosteroid withdrawal therapy for chronic hepatitis BHitomi Sezaki, Fumitaka Suzuki, Tetsuya Hosaka, et al.
Oncology|December 6, 2003
Recurrence rate and prognosis of patients with hepatocellular carcinoma that developed after elimination of hepatitis C virus RNA by interferon therapy. A closed cohort study including matched control patientsKenji Ikeda, Masahiro Kobayashi, Satoshi Saitoh, et al.
Intervirology|March 24, 2005
Hepatitis B virus-related hepatocellular carcinogenesis and its preventionKenji Ikeda, Yasuji Arase, Masahiro Kobayashi, et al.
Pageof 32